Episode Details

Agentic AI is moving from augmenting human work to acting autonomously — monitoring supply chains, adjusting production parameters, generating medical information responses. The EBITDA projections are enormous. So are the risks when an AI agent touches patients. We walk through the deployments, the economics, and the governance gap.

#pharma, #agentic AI, #commercial operations, #manufacturing, #digital twins, #supply chain, #EBITDA, #governance, #EU AI Act, #Novo Nordisk, #GSK, #Pfizer